Project Vision

Our Vision is to objectively and precisely unlock subtle facial clues to improve the lives of people living with genetic and rare diseases, and more common conditions, while enabling a collaborative community of research to advance genomic and personalised medicine.

The Project

Cliniface is a partnership between FrontierSI, Department of Health Western Australia, Curtin University, the Princess Margaret Hospital Foundation and Linear Clinical Research to develop a clinical platform for 3D facial analysis that can be used to assist clinical diagnosis, treatment monitoring, clinical trials and surgery.

The Need

Cliniface started to serve the needs of people living with rare diseases. Collectively 6-8% of people are estimated to be living with a rare disease. Diagnosis, treatment and clinical trials for people living with rare diseases can be extremely challenging. For instance, thirty per cent of rare diseases patients will be referred to an average of six specialists and can wait  years or  decades to receive a diagnosis. As subtle facial variations may provide critical clues for diagnosis, treatment monitoring and clinical trials, the need for a common interoperable digital tool that provides an objective means of measuring, analysing, determining and sharing facial variations, and that also supports existing and future research has become paramount.

Uses of Cliniface

  • Diagnostic assistance – genetic and rare diseases
  • Screening – Fetal Alcohol Spectrum Disorder (FASD)
  • Medical (drug) therapy monitoring – clinical trials and existing medicines; facial and systemic (whole body) conditions
  • Surgical Planning and Audit
  • Community engagement for science, medicine, arts and education – we all have a face